Recombinant Human Melanoma Inhibitory Activity Protein, >97%( SDS-PAGE and HPLC), high purity

Features and benefits
  • Expression System: E. coli
  • Accession #: Q16674
  • Protein Tag: No tag
  • Bioactivity: Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using human A375 cell line is less than 5 μg/ml, corresponding to a specific activity of > 200 IU/mg.
  • Endotoxin Concentration: <0.1 EU/μg
Item Number
rp148684
Grouped product items
SKUSizeAvailabilityPrice Qty
rp148684-10μg
10μg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$69.90
rp148684-50μg
50μg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$329.90
rp148684-100μg
100μg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$599.90
rp148684-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$4,999.90

Animal Free, >97%( SDS-PAGE and HPLC), Active, E.coli, No tag, 25-131aa

Basic Description

Product NameRecombinant Human Melanoma Inhibitory Activity Protein, >97%( SDS-PAGE and HPLC), high purity
SynonymsCD-RAP; Melanoma inhibitory activity protein; melanoma inhibitory activity; melanoma-derived growth regulatory protein; MIA
GradeActiBioPure™, Animal Free, Azide Free, Bioactive, Carrier Free, High Performance
Product Description

purity
>97% by SDS-PAGE and HPLC analysesFunction

Function
Elicits growth inhibition on melanoma cells in vitro as well as some other neuroectodermal tumors, including gliomas.

Post-translational
May possess two intramolecular disulfide bonds.

Specifications & PurityActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, High performance, ≥97%(SDS-PAGE&HPLC)
Purity>97%( SDS-PAGE and HPLC)
BioactivityFully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using human A375 cell line is less than 5 μg/ml, corresponding to a specific activity of > 200 IU/mg.
Endotoxin Concentration<0.1 EU/μg
Expression SystemE. coli
SpeciesHuman
Amino Acids25-131aa
SequenceGPMPKLADRKLCADQECSHPISMAVALQDYMAPDCRFLTIHRGQVVYVFSKLKGRGRLFW GGSVQGDYYGDLAARLGYFPSSIVREDQTLKPGKVDVKTDKWDFYCQ
Protein TagNo tag
Protein LengthProtein fragment
Accession #Q16674
SourceRecombinant
Predicted molecular weight12.1 kDa
SDS-PAGE12.1 kDa

Images

Recombinant Human Melanoma Inhibitory Activity Protein (rp148684)-Protein Bioactivity
Fully biologically active when compared to standard. The ED₅₀ as determined by a cell proliferation assay using human A375 cell line is less than 5 μg/mL, corresponding to a specific activity of > 200 IU/mg.

Recombinant Human Melanoma Inhibitory Activity Protein (rp148684)-SDS-PAGE
Recombinant Human Melanoma Inhibitory Activity Protein was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining. Showing a band at 12.1 kDa under reducing conditions and 10.3 kDa under non-reducing conditions.

Product Specifications

FormLyophilized
ReconstitutionCentrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/ml. This solution can then be diluted into other aqueous buffers and stored at 4oC for 1 week or -20oC for future use.
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
Stability And StorageUpon delivery aliquot, Store at -20°C, Avoid freeze/thaw cycles. This product is an active protein and may elicit a biological response in vivo, handle with caution.

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

3 results found

Lot NumberCertificate TypeDateItem
ZJ23F0600335Certificate of AnalysisMar 26, 2024 rp148684
ZJ23F0600336Certificate of AnalysisMar 26, 2024 rp148684
ZJ23F0600337Certificate of AnalysisMar 26, 2024 rp148684

Related Documents

References

1. Blesch, A A and 9 more authors..  (1994)  Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA..  Cancer research,    (1):   [PMID:7923218]
2. Bosserhoff, A K AK, Hein, R R, Bogdahn, U U and Buettner, R R..  (1996)  Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA..  The Journal of biological chemistry,    (5):   [PMID:8550608]
3. Lougheed, J C JC, Holton, J M JM, Alber, T T, Bazan, J F JF and Handel, T M TM..  (2001)  Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins..  Proceedings of the National Academy of Sciences of the United States of America,    (8):   [PMID:11331761]
4. Hau, Peter P and 7 more authors..  (2002)  Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIA/CD-RAP) [corrected]..  The Journal of investigative dermatology,      [PMID:12230496]
5. Zhang, Zemin Z and Henzel, William J WJ..  (2004)  Signal peptide prediction based on analysis of experimentally verified cleavage sites..  Protein science : a publication of the Protein Society,      [PMID:15340161]
6. Voss, Matthias M, Lettau, Marcus M and Janssen, Ottmar O..  (2009)  Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening..  BMC immunology,    (6):   [PMID:19807924]
7. Rahimi, Nader N, Rezazadeh, Kobra K, Mahoney, John E JE, Hartsough, Edward E and Meyer, Rosana D RD..  (2012)  Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesis..  Molecular biology of the cell,      [PMID:22419821]

Solution Calculators